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Background: The objective of this study was to investigate the 
association between A118G single nucleotide polymorphism (SNP) 
of human μ-opioid receptor (OPRM1) gene and the postoperative 
pain response in Korean patients undergoing thyroidectomy.
Methods: Fifty two adult patients undergoing thyroidectomy were 
enrolled in this study.  Their blood samples were genotyped for the 
A118G polymorphism.  Pain intensity was assessed by a verbal 
numerical rating scale (VNRS) at postanesthesia care unit, postope-
rative 6, 24, and 48 hours.  Mechanical pain threshold was assessed 
using electronic von Frey preoperatively and repeated at postope-
rative 24 and 48 hours on the forearm and periincisional regions.
Results: Of the 50 patients, 23 patients were A118 homozygous 
(AA), 19 patients were heterozygous (AG), and 8 patients were 
118G homozygous (GG).  The VNRS score was higher in patients 
with GG genotype than other genotypes at PACU (P ＜ 0.05).  
Mechanical pain thresholds on the forearm and periincisional area 
were decreased at postoperative 24 and 48 hours from the 
preoperative values in all genotypes (P ＜ 0.05).  However, the 
changes in pain thresholds were similar among the genotypes.
Conclusions: A118G SNP of OPRM1 gene is associated with 
inter-individual difference in immediate postoperative pain score in 
Korean population.  (Anesth Pain Med 2012; 7: 343∼347)
Key Words: Mechanical pain threshold, Opioid receptor, Pain, 
Polymorphism.
INTRODUCTION
Postoperative pain is a common and distressing complication 
in patients undergoing surgery. Various analgesics such as 
opioids have been used to reduce moderate to severe pain 
during perioperative periods. However, the pain perception after 
surgery is well known to vary among different individuals [1], 
therefore, it is difficult to predict the pain response after 
surgery in some patients. Although the mechanism of this 
inter-individual difference is not clear, genetic factors may play 
an important role.
The human μ-opioid receptor (OPRM1) gene regulates the 
analgesic effect of endogenous and exogenous opioids, and the 
function of OPRM1 gene has been found to be associated with 
the single nucleotide polymorphism (SNP) of this gene [2-4]. 
Among various SNPs, the most common SNP in the OPRM1 
is the A118G SNP occurring at nucleotide 118 consisting of 
adenine (A) to guanine (G) transition. Several studies investi-
gated the clinical implication of A118G SNP of OPRM1 for 
pain response. However, the effect of this polymorphism on 
pain perception and analgesic requirement for postoperative 
pain is controversial [5,6]. Moreover, ethnicity is regarded as 
an independent predictor of postoperative pain perception [7]. 
To our knowledge, the relationship between A118G SNP of 
OPRM1 and the pain response in Korean populations has not 
been investigated. Therefore, in this study, we investigated the 
association between A118G SNP of OPRM1 and the postope-
rative pain response in Korean patients undergoing thyroidec-
tomy.
MATERIALS AND METHODS
After obtaining approval from Institutional Review Board, 
written informed consent was obtained from each patient. Fifty 
two adult patients (American Society of Anesthesiologists 
physical status classification 1−2) undergoing thyroidectomy 
were enrolled in this study. We excluded patients with a drug 
abuse, chronic pain or psychiatric history, known hypersen-
sitivity to opioids, and use of opioids within 24 hours before 
the study. Patients with hepatic or renal disease were also 
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excluded. Before the surgery, all patients were instructed about 
the use of the verbal numerical rating scale (VNRS) and given 
a quantitative sensory test (QST) of mechanical threshold using 
electronic von Frey (EVF3TM, Bioseb, Vitrolles Cedex, France). 
No premedication was administered to the patients. Electro-
cardiography, noninvasive blood pressure and pulse oximetry 
were monitored continuously after the patient’s arrival at the 
operating room. Anesthesia was induced with thiopental 4−5 
mg/kg, remifentanil 0.5 μg/kg and rocuronium 0.6 mg/kg 
intravenously. The trachea was intubated and the patient’s 
lungs were ventilated with 50% oxygen in air. Sevoflurane 1.5
−2.0 vol% and remifentanil 0.1−0.2 µg/kg/min were used for 
maintenance of anesthesia. A bispectral index score (BIS) 
monitor (A-2000 BIS MonitorTM, Aspect Medical System Inc., 
Newton, USA) was monitored continuously to maintain 
between 45 and 55 during the procedure. Patients were kept 
warm using a forced-air warming system (Bair-HuggerTM, 
Augustine-Medical, Eden Prairie, MN, USA) to maintain body 
temperature at 36.0−37.0oC. Thirty minutes before the end of 
surgery, ondansetron 0.1 mg/kg was administered intravenously 
for prevention of postoperative nausea and vomiting (PONV). 
At the end of surgery, neuromuscular block was reversed with 
neostigmine 0.03 mg/kg and glycopyrrolate 0.004 mg/kg. After 
adequate spontaneous respiration, endotracheal extubation was 
performed. Patients who reported a VNRS score ＞ 4 or 
requested analgesics were treated with tramadol 50 mg IM. 
The total dose of remifentanil consumption during anesthesia, 
and awakening time were recorded. 
Pain intensity was assessed by an 11-point VNRS for 
postoperative 48 hours: 15 min after postanesthesia care unit 
(PACU) admission, postoperative 6, 24, and 48 hours. Possible 
complications such as PONV, headache, and drowsiness were 
also recorded at the same time. Mechanical pain threshold was 
assessed using electronic von Frey preoperatively and repeated 
at postoperative 24 and 48 hours on the forearm and 3 
periincisional regions (both ends and middle of the horizontal 
skin incision), and a mean value was calculated. 
All patients underwent peripheral blood sampling for 
isolation of genomic DNA. Samples were stored at −20oC 
until DNA extraction. Genomic DNA was prepared from 
peripheral blood samples using a nucleic acid isolation device, 
QuickGene-mini80 (FUJIFILM, Tokyo, Japan). The genotyping 
of A118G opioid receptor gene variants (rs1799971) was 
screened using single base primer extension assay using ABI 
PRISM SNaPShot Multiplex kit (ABI, Foster City, CA, USA) 
according to manufacturer’s recommendation. Briefly, the 
genomic DNA was amplified with polymerase chain reaction 
(PCR) with forward (F) and reverse (R) primer pairs and 
standard PCR reagents in 10 μl reaction volume, containing 
10 ng of genomic DNA, 0.5 pM of each oligonucleotide 
primer, 1 μl of 10X PCR buffer, 250 μM dNTP and 0.25 U 
i-StarTaq DNA polymerase (iNtRON Biotechnology, Sungnam, 
Kyungki-Do, Korea). Primers were designed on the basis of 
target gene sequences: 5´-GTGATGAGCCTCTGTGAACT-3´ 
(F), 5´-TCACATACATGACCAGGAAG-3  ´ (R). The PCR reac-
tions were carried out as follows: one cycle at 95oC for 10 
min, and 35 cycles at 95oC for 30 s, 55oC for 1 min, 72oC 
for 1 min followed by one cycle of 72oC for 10 min. After 
amplification, the PCR products were treated with 1 U each of 
shrimp alkaline phosphatase (SAP) (USB Corporation, 
Cleveland, OH, USA) and exonuclease I (USB Corporation, 
Cleveland, OH, USA) at 37oC for 75 min and 72oC for 15 
min to purify the amplified products. One μl of the purified 
amplification products were added to the SNaPshot Multiplex 
Ready reaction mixture containing 0.15 pM of genotyping pri-
mer (GGTCAACTTGTCCCACTTAGATGGC) for primer exten-
sion reaction. The primer extension reaction was carried out 
for 25 cycles of 96oC for 10 s, 50oC for 5 s, and 60oC for 
30 s. The reaction products were treated with 1 U of SAP at 
37oC for 1 hour and 72oC for 15 min to remove excess 
fluorescent dye terminators. One μl of the final reaction 
samples containing the extension products were added to 9 μl 
of Hi-Di formamide (ABI, Foster City, CA, USA). The 
mixture was incubated at 95oC for 5 min, followed by 5 min 
on ice and then analyzed by electrophoresis in ABI Prism 
3730xl DNA analyzer (Applied Biosystems, USA). Analysis 
was carried out using Genemapper software (version 4.0; 
Applied Biosystems, USA). 
Data were analyzed using SPSS version 13.5 (SPSS Inc., 
Chicago, IL, USA). All values were expressed as mean ± SD 
or number of patients. The frequency of the SNP was assessed 
for deviation from Hardy-Weinberg equilibrium using Fisher’s 
exact test. Frequency differences in genotype, demographic 
data, VNRS, and mechanical pain threshold were compared by 
chi-square test, Fisher’s exact test, ANOVA with Bonferroni 
correction and Kruskal-Wallis test as appropriate. A P ＜ 0.05 
was considered significant.
RESULTS
A total of 52 patients were enrolled on this study. However, 
two cases were excluded due to technical errors in gene 
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Table 1. Genotypes Frequency of Human μ-Opioid Receptor A118G 
Polymorphism
A118G genotypes
AA AG GG Total
23 (46) 19 (38) 8 (16) 50
Values are number of patients (%). AA: wild homozygous, AG: 
mutant heterozygous, GG: mutant homozygous. 
Table 2. Demographic and Clinical Data 
AA AG GG
Sex (M/F)
Age (yr)
Weight (kg)
Height (cm)
Duration of 
anesthesia (min)
Remifentanil dose 
(μg)
Awakening time 
(min)
5/18
 44.9 ± 11.4
 59.6 ± 9.0
161.8 ± 6.3
111.3 ± 33.2
739.6 ± 320.6
  8.1 ± 4.2
5/14
 42.1 ± 9.9
 66.3 ± 13.5
161.8 ± 8.3
131.9 ± 47.1
862.0 ± 392.6
  8.2 ± 4.3
2/6
 42.3 ± 10.9
 63.4 ± 9.2
164.6 ± 8.5
122.9 ± 42.9
828.3 ± 200.1
  7.9 ± 2.2
Values are mean ± SD or number of patients. AA: wild homozy-
gous, AG: mutant heterozygous, GG: mutant homozygous. 
Table 3. Pain Scores and Analgesic Consumption
AA (n = 23) AG (n = 19) GG (n = 8)
VNRS
PACU
Postoperative 6 h
Postoperative 24 h
Postoperative 48 h
Rescue analgesics 
 5 (3−7)
 4 (2−6)
 3 (1−5)
 2 (1−3)
15 (65.2)
 6 (4−8)
 3 (1−5)
 3 (2−4)
 2 (1−3)
12 (63.2)
7 (5−9)*
3 (1−5)
3 (2−4)
2 (1−3)
6 (75.0)
Values are median (range) or number of patients (%). AA: wild 
homozygous, AG: mutant heterozygous, GG: mutant homozygous, 
VNRS: verbal numerical rating scale, PACU: postanesthesia care 
unit. *P ＜ 0.05 compared with AA and AG.
Table 4. Mechanical Pain Thresholds
Mechanical pain 
thresholds (g) AA (n =23) AG (n =19) GG (n =8)
Forearm
  Preoperative
  Postoperative 24 h
  Postoperative 48 h
Periincisional area
  Preoperative
  Postoperative 24 h
  Postoperative 48 h
125.5 ± 54.8
 92.4 ± 40.6*
 89.1 ± 36.9*
 99.3 ± 66.7
 79.0 ± 43.6*
 80.0 ± 30.3*
122.6 ± 58.0
 94.0 ± 32.5*
 98.4 ± 51.1*
 97.2 ± 40.8
 82.0 ± 42.1*
 83.1 ± 25.3*
116.7 ± 47.8
 83.0 ± 41.8*
 93.1 ± 48.9*
 93.1 ± 51.8
 78.7 ± 42.2*
 80.1 ± 54.9*
Values are mean ± SD. AA: wild homozygous, AG: mutant hetero-
zygous, GG: mutant homozygous. *P ＜ 0.05 compared with preo-
perative values.
Table 5. Incidence of Adverse Effects for Postoperative 48 Hours
AA (n =23) AG (n =19) GG (n =8)
PONV
Headache
Drowsiness
Dizziness
8
1
3
1
7
2
3
1
3
1
1
1
Values are number of patients. AA: wild homozygous, AG: mutant 
heterozygous, GG: mutant homozygous. PONV: postoperative nausea 
and vomiting. 
analysis. Hence, data from 50 patients were analyzed in this 
study. Genotype frequencies are summarized in Table 1. Of 
the 50 patients, 23 patients were A118 homozygous (AA), 19 
patients were heterozygous (AG), and 8 patients were 118G 
homozygous (GG). The genotype frequencies of OPRM1 SNPs 
were in Hardy-Weinberg equilibrium. There were no significant 
differences in demographic and clinical data according to 
genotypes (Table 2). 
Pain scores were similar among the genotypes except at 
PACU. The VNRS score was higher in patients with GG 
genotype than other genotypes at PACU (P ＜ 0.05). There 
were no significant differences in the number of patients who 
requested rescue analgesics among the 3 genotypes (Table 3). 
Mechanical pain thresholds on the forearm and periincisional 
area were decreased at postoperative 24 and 48 hours from the 
preoperative values in all genotypes (P ＜ 0.05). However, the 
changes in pain thresholds were similar among the genotypes 
(Table 4). 
There were no significant differences in the incidence of 
PONV, headache, drowsiness, and dizziness among the 3 
genotypes (Table 5).
DISCUSSION
Our study demonstrates that there was an association 
between A118G SNP of OPRM1 gene and the immediate 
postoperative pain score in Korean patients. The VNRS score 
was higher in patients with GG genotype than other genotypes 
at PACU. 
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There are some evidences that genetic polymorphism of 
OPRM1 gene may influence the pain response and analgesic 
requirement [8-12]. In a recent study, A118G SNP was 
associated with pain perception and patient-controlled intra-
venous morphine consumption for postcesarean analgesia [1]. In 
this study, we also found an association between A118G SNP 
of OPRM1 gene and the postoperative pain score at PACU in 
patient undergoing thyroidectomy. It is likely that patients with 
118GG genotype have a greater pain perception due to 
increased pain sensitivity in the immediate postoperative 
periods. Postoperative pain is a very serious distress after 
surgery. Therefore, if we are able to expect the pain response 
after surgery, personalized pain treatment can be provided with 
less complication. However, further study should be performed 
to evaluate the effect of genetic polymorphism in OPRM1 
gene on the opioid receptor expression in pain process. 
We found that the pain response during 6−48 hours after 
surgery did not differ according to genotypes. In this study, 
almost 90% or more of all patients undergoing thyroidectomy 
did not suffer pain between 6 and 48 hours. Therefore, this 
may explain the lack of association at this time period. The 
number of patients who requested rescue analgesics was 
slightly higher in patients with 118GG genotype; however, it 
was statistically insignificant due to small sample size of 
patients with GG genotype.
In this study, we could find that the allele frequency for the 
118G allele in Korean population was 0.350. This frequency is 
similar to the other Asian populations whose reported range is 
0.321−0.485 [4,13,14], and significantly higher than the range 
of 0.074−0.200 reported for Caucasian population [10,14,15]. 
Tan, et al. demonstrated that there was an ethnic difference in 
pain perception and patient-controlled analgesia usage for 
postoperative pain [16]. They also reported that ethnicity would 
be the most significant factor to opioid usage after surgery. In 
this study, our study sample is the most homogenous in that it 
involved only Korean patients undergoing the same surgery; 
therefore it represents the association between A118G SNP of 
OPRM1 gene and the postoperative pain score in Korean 
patients.
Previous studies evaluated the association between a quanti-
tative sensory test (QST) and opioid receptor gene polymor-
phism with contradictory results. Fillingim et al. [17] demon-
strated that the A118G SNP of OPRM1 gene was associated 
with pressure pain sensitivity in healthy adult. However, Huang 
et al. [5] reported that there was no significant association bet-
ween the A118G SNP of OPRM1 gene and pressure pain thre-
shold. Although the mechanisms that represent the inter-indivi-
dual variability in pain sensitivity is unclear, we found that the 
changes in mechanical pain thresholds were similar among the 
A118G OPRM1 genotypes in Korean population.
There are several contributing factors affecting postoperative 
pain. It is well known that gender and a type of surgery are 
risk factors for postoperative pain [18]. In this study, there 
were no significant differences in gender ratios according to 
genotypes. Moreover, other factors that affect postoperative 
pain such as anesthetic agent and type of surgery, were also 
controlled in this study, therefore, they would have minimal 
effect on our results. 
There are several limitations to our study. First, the sample 
size is relatively small for a genetic association study. Sample 
size calculation was performed based on a preliminary study. 
The sample size required to detect a mean difference of 2 in 
VAS with a SD of 1.7 and a power of 80% at an alpha level 
of 0.05 was 24 patients in AA group. On the basis of an 
estimated prevalence of A118G SNP of OPRM1 gene in the 
preliminary study, we calculated that we needed at least 52 
patients to be enrolled. It may not be appropriate to apply our 
result to clinical practice, as a larger scale study should be 
required to demonstrate the clinical implication of genetic 
variation of OPRM1 gene. Although a larger scale study will 
be required, this results may be helpful to present the basic 
information of personalized pain management in Korean 
population. Second, we evaluated only one polymorphism of 
the opioid receptor gene. Further studies about other poly-
morphisms that can affect the activity of receptor, drug 
transporter, and drug metabolizing enzyme will be required.
In conclusion, A118G SNP of OPRM1 gene is associated 
with inter-individual difference in immediate postoperative pain 
score in Korean population. Therefore, OPRM1 gene genotypes 
may be a clinical predictor for immediate postoperative pain. 
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